Kurt F. Somerville’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.59M Sell
10,438
-540
-5% -$82.8K 0.42% 42
2025
Q4
$1.51M Sell
10,978
-2,345
-18% -$307K 0.26% 44
2025
Q3
$1.71M Sell
13,323
-1,000
-7% -$122K 0.28% 45
2025
Q2
$1.73M Sell
14,323
-1,770
-11% -$200K 0.29% 44
2025
Q1
$1.79M Sell
16,093
-1,035
-6% -$110K 0.31% 43
2024
Q4
$1.67M Sell
17,128
-7,980
-32% -$851K 0.28% 43
2024
Q3
$2.89M Sell
25,108
-6,117
-20% -$694K 0.46% 39
2024
Q2
$3.32M Sell
31,225
-22,259
-42% -$2.23M 0.56% 38
2024
Q1
$5.17M Sell
53,484
-42,365
-44% -$4.34M 0.89% 31
2023
Q4
$9.68M Sell
95,849
-28,508
-23% -$2.75M 1.82% 23
2023
Q3
$12.7M Sell
124,357
-4,593
-4% -$466K 2.55% 19
2023
Q2
$13M Sell
128,950
-15,440
-11% -$1.54M 2.48% 19
2023
Q1
$13.3M Buy
144,390
+785
+0.5% +$68.6K 2.42% 18
2022
Q4
$13M Sell
143,605
-10,295
-7% -$867K 2.53% 18
2022
Q3
$11.7M Sell
153,900
-1,155
-0.7% -$95.7K 2.35% 18
2022
Q2
$13.1M Sell
155,055
-6,457
-4% -$566K 2.49% 17
2022
Q1
$14.2M Sell
161,512
-13,140
-8% -$1.14M 2.28% 20
2021
Q4
$15.3M Sell
174,652
-5,234
-3% -$435K 2.12% 20
2021
Q3
$14.7M Sell
179,886
-738
-0.4% -$66.4K 2.23% 21
2021
Q2
$16.5M Sell
180,624
-630
-0.3% -$56.1K 2.46% 19
2021
Q1
$15.5M Buy
181,254
+2,170
+1% +$195K 2.45% 19
2020
Q4
$16.9M Buy
179,084
+1,700
+1% +$149K 2.75% 17
2020
Q3
$15.4M Buy
177,384
+828
+0.5% +$71.7K 2.72% 15
2020
Q2
$15.4M Buy
176,556
+185
+0.1% +$16K 2.84% 15
2020
Q1
$14.5M Buy
176,371
+4,035
+2% +$360K 3.22% 14
2019
Q4
$16.3M Sell
172,336
-1,572
-0.9% -$141K 3.06% 14
2019
Q3
$15.1M Sell
173,908
-376
-0.2% -$33.8K 2.99% 15
2019
Q2
$15.9M Sell
174,284
-26,040
-13% -$2.2M 3.16% 12
2019
Q1
$17.3M Buy
200,324
+246
+0.1% +$19.7K 3.42% 8
2018
Q4
$15.4M Buy
200,078
+1,094
+0.5% +$85.2K 3.53% 8
2018
Q3
$15.4M Buy
198,984
+3,444
+2% +$255K 3.07% 11
2018
Q2
$13.2M Buy
195,540
+2,091
+1% +$144K 2.92% 12
2018
Q1
$14M Sell
193,449
-8,326
-4% -$634K 3.1% 12
2017
Q4
$15.2M Sell
201,775
-16,006
-7% -$1.21M 3.14% 10
2017
Q3
$16.8M Buy
217,781
+1,066
+0.5% +$80.5K 3.34% 10
2017
Q2
$16.2M Buy
216,715
+3,303
+2% +$234K 3.31% 11
2017
Q1
$14.2M Sell
213,412
-4,149
-2% -$276K 3% 12
2016
Q4
$14.2M Sell
217,561
-1,647
-0.8% -$107K 3.15% 12
2016
Q3
$15.5M Buy
219,208
+7,812
+4% +$569K 3.38% 9
2016
Q2
$15.6M Buy
211,396
+5,946
+3% +$411K 3.51% 9
2016
Q1
$13.3M Buy
205,450
+2,024
+1% +$138K 3.04% 11
2015
Q4
$15.7M Buy
203,426
+16,215
+9% +$1.29M 3.58% 5
2015
Q3
$15.4M Sell
187,211
-951
-0.5% -$84.6K 3.93% 3
2015
Q2
$16.6M Buy
188,162
+1,826
+1% +$168K 3.83% 3
2015
Q1
$16.5M Buy
186,336
+20,123
+12% +$1.78M 3.74% 3
2014
Q4
$13.8M Buy
166,213
+55,430
+50% +$4.59M 3.43% 6
2014
Q3
$9.34M Sell
110,783
-1,337
-1% -$108K 3.77% 5
2014
Q2
$9.1M Sell
112,120
-1,055
-0.9% -$83K 3.55% 5
2014
Q1
$8.62M Sell
113,175
-6,077
-5% -$443K 3.43% 7
2013
Q4
$8.59M Sell
119,252
-4,771
-4% -$332K 3.29% 8
2013
Q3
$8.52M Buy
124,023
+491
+0.4% +$32.5K 3.4% 7
2013
Q2
$7.83M Buy
+123,532
New +$8.04M 3.29% 8

Other funds holding NVS

Kurt F. Somerville's NVS Position: Q1 2026 in Review

Kurt F. Somerville reduced its Novartis (NVS) stake by 4.9% in Q1 2026, selling an estimated $82.8K and leaving 10,438 shares worth $1.59M. The position accounts for 0.42% of the portfolio, ranked #42.

Kurt F. Somerville first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.3M in Q1 2019. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Kurt F. Somerville held 10,438 shares of Novartis worth $1.59M as of Q1 2026.
  • Kurt F. Somerville sold 540 Novartis shares in Q1 2026, an estimated $82.8K.
  • Novartis made up 0.42% of Kurt F. Somerville's portfolio in Q1 2026, its #42 holding.
  • Kurt F. Somerville first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
  • Kurt F. Somerville's Novartis position peaked at $17.3M in Q1 2019.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Kurt F. Somerville's 13F filing for Q1 2026, filed 8 May 2026.